AAAAAA
Results:
1-15
|
Results: 15
Authors:
Mehta, PD
Pirttila, T
Patrick, BA
Barshatzky, M
Mehta, SP
Citation: Pd. Mehta et al., Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease, NEUROSCI L, 304(1-2), 2001, pp. 102-106
Authors:
Kerokoski, P
Soininen, H
Pirttila, T
Citation: P. Kerokoski et al., beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality, NEUROCHEM I, 38(2), 2001, pp. 127-134
Authors:
Tapiola, T
Soininen, H
Pirttila, T
Citation: T. Tapiola et al., CSF tau and A beta 42 levels in patients with Down's syndrome, NEUROLOGY, 56(7), 2001, pp. 979-979
Authors:
Luostarinen, L
Dastidar, P
Collin, P
Peraaho, M
Maki, M
Erila, T
Pirttila, T
Citation: L. Luostarinen et al., Association between coeliac disease, epilepsy and brain atrophy, EUR NEUROL, 46(4), 2001, pp. 187-191
Authors:
Kerokoski, P
Suuronen, T
Salminen, A
Soininen, H
Pirttila, T
Citation: P. Kerokoski et al., The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis, BIOC BIOP R, 280(4), 2001, pp. 998-1002
Authors:
Tapiola, T
Pirttila, T
Mikkonen, M
Mehta, PD
Alafuzoff, I
Koivisto, K
Soininen, H
Citation: T. Tapiola et al., Three-year follow-up of cerebrospinal fluid tau, beta-amyloid 42 and 40 concentrations in Alzheimer's disease, NEUROSCI L, 280(2), 2000, pp. 119-122
Authors:
Tapiola, T
Pirttila, T
Mehta, PD
Alafuzoff, I
Lehtovirta, M
Soininen, H
Citation: T. Tapiola et al., Relationship between apoE genotype and CSF beta-amyloid (1-42) and tan in patients with probable and definite Alzheimer's disease, NEUROBIOL A, 21(5), 2000, pp. 735-740
Authors:
Mehta, PD
Pirttila, T
Mehta, SP
Sersen, EA
Aisen, PS
Wisniewski, HM
Citation: Pd. Mehta et al., Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease, ARCH NEUROL, 57(1), 2000, pp. 100-105
Authors:
Pirttila, T
Haanpaa, M
Mehta, PD
Lehtimaki, T
Citation: T. Pirttila et al., Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster, ACT NEUR SC, 102(2), 2000, pp. 94-98
Authors:
Hautaniemi, P
Pirttila, T
Citation: P. Hautaniemi et T. Pirttila, The choice of replenishment policies in an MRP environment, INT J PRO E, 59(1-3), 1999, pp. 85-92
Authors:
Luostarinen, L
Himanen, SL
Pirttila, T
Molnar, G
Citation: L. Luostarinen et al., Mixed connective tissue disease associated with chronic inflammatory demyelinating polyneuropathy, SC J RHEUM, 28(5), 1999, pp. 328-330
Authors:
Wegiel, J
Wisniewski, HM
Morys, J
Tarnawski, M
Kuchna, I
Dziewiatkowski, J
Pirttila, T
Krivimaki, T
Lehtimaki, T
Lach, B
Citation: J. Wegiel et al., Neuronal loss and beta-amyloid removal in the amygdala of people with Downsyndrome, NEUROBIOL A, 20(3), 1999, pp. 259-269
Authors:
Luostarinen, L
Pirttila, T
Collin, P
Citation: L. Luostarinen et al., Coeliac disease presenting with neurological disorders, EUR NEUROL, 42(3), 1999, pp. 132-135
Authors:
Tapiola, T
Lehtovirta, M
Pirttila, T
Alafuzoff, I
Riekkinen, P
Soininen, H
Citation: T. Tapiola et al., Cerebrospinal fluid aspartate aminotransferase activity is increased in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 193-197
Authors:
Mattila, KM
Forsell, C
Pirttila, T
Rinne, JO
Lehtimaki, T
Roytta, M
Lilius, L
Eerola, A
St George-Hyslop, PH
Frey, H
Lannfelt, L
Citation: Km. Mattila et al., The Glu318Gly mutation of the presenilin-1 gene does not necessarily causeAlzheimer's disease, ANN NEUROL, 44(6), 1998, pp. 965-967
Risultati:
1-15
|